Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Derivatives of 2-(1,2,4-triazol-3-ylsulfanyl)-N-1,3,4-thiadiazol-2-yl acetamide which are useful for the treatment of inter alia diabetes

Derivatives of 2-(1,2,4-triazol-3-ylsulfanyl)-N-1,3,4-thiadiazol-2-yl acetamide which are useful for the treatment of inter alia diabetes

US Patent 10011597 · Granted Jul 3, 2018

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Galactoside inhibitor of galectins2025
Galactoside inhibitor of galectins2024
Holding device for load handling tool and hydraulic crane comprising such a hold2023
Galactoside inhibitor of galectins2022
2-oxothiatole compounds having activity as cPLA2 inhibitors for the treatment of2020
2-oxothiatole compounds having activity as cPLA2 inhibitors for the treatment of2020
Galactoside inhibitor of galectins2020
Compounds for modulating aquaporins2020
Compounds for modulating aquaporins2020
Compounds for modulating aquaporins2020
1,1 ′-sulfanediyl-di-beta-D-galactopyranosides as inhibitors of galectins2020
Galactoside inhibitor of galectins2020